Polypeptides having a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides for the screening of substances active on these polypeptides
US5407823A · kind A · utility
8Cited by
1References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 31, 1991 |
| Grant date | Apr 18, 1995 |
| Priority date | — |
| Expiry date | Dec 31, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to novel polypeptides having dopaminergic receptor activity and nucleic acid sequences encoding these novel polypeptides. The novel polypeptides are useful as drugs and/or to screen other drugs that affect dopaminergic receptors. The nucleic acid sequences are useful as diagnostic agents and to prepare transformed cells and vectors expressing the novel polypeptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.